153 related articles for article (PubMed ID: 12941730)
1. Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes.
Roguin A; Koch W; Kastrati A; Aronson D; Schomig A; Levy AP
Diabetes Care; 2003 Sep; 26(9):2628-31. PubMed ID: 12941730
[TBL] [Abstract][Full Text] [Related]
2. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
[TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A
Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992
[TBL] [Abstract][Full Text] [Related]
4. An open design, multicentre, randomized trial of percutaneous transluminal coronary angioplasty versus stenting, with a heparin-coated stent, of totally occluded coronary arteries: rationale, trial design and baseline patient characteristics. Total Occlusion Study of Canada (TOSCA) Investigators.
Dzavik V; Carere RG; Teo KK; Knudtson ML; Marquis JF; Buller CE
Can J Cardiol; 1998 Jun; 14(6):825-32. PubMed ID: 9676168
[TBL] [Abstract][Full Text] [Related]
5. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
6. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous transluminal coronary angioplasty (PTCA) combined with stenting improves clinical outcomes compared with PTCA alone in acute myocardial infarction.
Koneru S; Monsen CE; Pucillo A; Cohen MB; McClung J; Weiss MB
Heart Dis; 2000; 2(4):282-6. PubMed ID: 11728270
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients.
Waldecker B; Waas W; Haberbosch W; Voss R; Steen-Müller MK; Hiddessen A; Bretzel R; Tillmanns H
Diabetes Care; 1999 Nov; 22(11):1832-8. PubMed ID: 10546016
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.
Rana JS; Monraats PS; Zwinderman AH; de Maat MP; Kastelein JJ; Doevendans PA; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW;
Diabetes Care; 2005 Apr; 28(4):873-7. PubMed ID: 15793188
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
11. [Long term outcome in patients with and without restenosis after coronary angioplasty].
Przewłocki T; Ryniewicz W; Sokołowski A; Pieniazek P; Olszowska M; Kostkiewicz M; Lelakowski J; Tracz W
Przegl Lek; 2001; 58(9):845-50. PubMed ID: 11868245
[TBL] [Abstract][Full Text] [Related]
12. Inflection point of ascending aortic waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.
Ueda H; Nakayama Y; Tsumura K; Yoshimaru K; Hayashi T; Yoshikawa J
Am J Hypertens; 2002 Sep; 15(9):823-6. PubMed ID: 12219879
[TBL] [Abstract][Full Text] [Related]
13. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.
Hoffmann R; Stellbrink E; Schröder J; Grawe A; Vogel G; Blindt R; Kelm M; Radke PW
Am J Cardiol; 2007 Nov; 100(9):1347-52. PubMed ID: 17950788
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis.
Hsu LF; Mak KH; Lau KW; Sim LL; Chan C; Koh TH; Chuah SC; Kam R; Ding ZP; Teo WS; Lim YL
Heart; 2002 Sep; 88(3):260-5. PubMed ID: 12181218
[TBL] [Abstract][Full Text] [Related]
15. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
[TBL] [Abstract][Full Text] [Related]
17. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease.
Park DW; Hong MK; Suh IW; Hwang ES; Lee SW; Jeong YH; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2007 Mar; 99(6):760-5. PubMed ID: 17350360
[TBL] [Abstract][Full Text] [Related]
18. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
[TBL] [Abstract][Full Text] [Related]
19. Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery.
Mehta RH; Harjai KJ; Boura JA; Tcheng JE; Dixon SR; Stone GW; Grines CL
Am Heart J; 2013 Jun; 165(6):1000-7. PubMed ID: 23708173
[TBL] [Abstract][Full Text] [Related]
20. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
